Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP)

Exclusion Criteria

• •Graft retrieved in an adult donor
• •Graft from a deceased donor after brain death (DBD)
• •Graft locally transplanted in one of the 6 kidney transplant centers participating in the study
• •Graft stored in preservation solution containing HEMO2Life®
• •For Patient :
• •Patient who signed an inform consent form In case of patient unable to signed an inform consent form for patient under judicial protection (supervision, guardianship) the inform consent form will be obtain from the patient himself and from the supervisor/guardianshiper/parents, they will signed together the patient inform consent form.
• •The probability of the inclusion of a patient unable to signed an inform consent form is low but we can't know the receiver before conditioning the graft.
• •Patient \> 18 years old
• •Graft from a living donor
• •Graft from a donor after cardiovascular death (DCD)
• •Graft dedicated to a multi-organ transplantation